TONIX PHARMACEUTICALS HOLDING CORP. Adjustments to Additional Paid in Capital, Other
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Adjustments to Additional Paid in Capital, Other of -$9.98 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-03-12
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, other for the quarter ending 2024-06-30 was -$9.98M.
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, other for fiscal 2024 was -$9.98M.
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, other for fiscal 2012 was $3.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | -$9.98M 10-K · filed 2026-03-12 | ||
| 2024-06-30 | -$9.98M 10-Q · filed 2025-11-10 | ||
| 2012-12-31 | $3.00K 10-K · filed 2014-03-28 | $3.11K 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |